4.8 Article

Mutations disrupting neuritogenesis genes confer risk for cerebral palsy

Journal

NATURE GENETICS
Volume 52, Issue 10, Pages 1046-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41588-020-0695-1

Keywords

-

Funding

  1. Cerebral Palsy Alliance Research Foundation
  2. Yale-NIH Center for Mendelian Genomics [U54 HG006504-01]
  3. Doris Duke Charitable Foundation [CSDA 2014112]
  4. Scott Family Foundation
  5. Cure CP
  6. NHMRC [1099163]
  7. NHMRC Senior Principal Research Fellowship [1155224]
  8. Channel 7 Children's Research Foundation
  9. Cerebral Palsy Alliance Research Foundation Career Development Award
  10. Tenix Foundation
  11. National Natural Science Foundation of China [U1604165]
  12. Henan Key Research Program of China [171100310200]
  13. VINNOVA [2015-04780]
  14. James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowship at the Yale University School of Medicine
  15. American Heart Association Postdoctoral Fellowship [18POST34060008]
  16. NIH K99/R00 Pathway to Independence Award [R00HL143036-02]
  17. NIH [R01NS106298, R01NS091299]
  18. National Health and Medical Research Council of Australia [1099163, 1155224] Funding Source: NHMRC

Ask authors/readers for more resources

Whole-exome sequencing of 250 parent-offspring trios identifies an enrichment of rare damaging de novo mutations in individuals with cerebral palsy and implicates genetically mediated dysregulation of early neuronal connectivity in the etiology of this disorder. In addition to commonly associated environmental factors, genomic factors may cause cerebral palsy. We performed whole-exome sequencing of 250 parent-offspring trios, and observed enrichment of damaging de novo mutations in cerebral palsy cases. Eight genes had multiple damaging de novo mutations; of these, two (TUBA1AandCTNNB1) met genome-wide significance. We identified two novel monogenic etiologies,FBXO31andRHOB, and showed that theRHOBmutation enhances active-state Rho effector binding while theFBXO31mutation diminishes cyclin D levels. Candidate cerebral palsy risk genes overlapped with neurodevelopmental disorder genes. Network analyses identified enrichment of Rho GTPase, extracellular matrix, focal adhesion and cytoskeleton pathways. Cerebral palsy risk genes in enriched pathways were shown to regulate neuromotor function in aDrosophilareverse genetics screen. We estimate that 14% of cases could be attributed to an excess of damaging de novo or recessive variants. These findings provide evidence for genetically mediated dysregulation of early neuronal connectivity in cerebral palsy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available